197

Drug Discovery
Sub Categories on Drug Discovery
Latest Articles
FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme

FDA approves Breyanzi for relapsed, refractory marginal zone lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatme
Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum

Study finds 40% of GLP-1 prescriptions go unfilled: Is cost curbing use of weight loss drugs?

by Alvin Powell, Harvard GazetteRate of fill of glucagon-like peptide-1 (GLP-1) receptor agonist orders by race, ethnicity, and indication. Credit:JAMA Health Forum(2025). DOI: 10.1001/jamahealthforum